- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia Syndrome
This study is looking into a new medication called ARO-APOC3 for adults with a rare genetic condition called Familial Chylomicronemia Syndrome (FCS). Researchers want to see if this new medicine can help lower high levels of fats in the blood and if it's safe to use.
For: Familial Chylomicronemia Syndrome (FCS)Ireland · France · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults with Dyslipidemia
This study is looking at a new medicine called ARO-APOC3 for people with a common type of high cholesterol and fats in their blood. Researchers want to see if it's safe to use long-term and how well it helps to lower these unhealthy levels.
For: Mixed DyslipidemiaPoland · Hungary · Netherlands